Narrow search
Showing 1 - 10 of 4,841
Cover Image
Organizational scope and investment : evidence from the drug development strategies and performance of biopharmaceutical firms
Guedj, Ilan; Scharfstein, David - 2004
Persistent link: https://www.econbiz.de/10002481759
Cover Image
Organizational Scope and Investment : Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
Guedj, Ilan - 2014
This paper compares the clinical trial strategies and performance of large, established (quot;maturequot;) biopharmaceutical firms to those of smaller (quot;early stagequot;) firms that have not yet successfully developed a drug. We study a sample of 235 cancer drug candidates that entered...
Persistent link: https://www.econbiz.de/10012752635
Cover Image
Organizational Scope and Investment : Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
Guedj, Ilan - 2004
This paper compares the clinical trial strategies and performance of large, established ("mature") biopharmaceutical firms to those of smaller ("early stage") firms that have not yet successfully developed a drug. We study a sample of 235 cancer drug candidates that entered clinical trials...
Persistent link: https://www.econbiz.de/10012467754
Cover Image
Corporate governance and alternative performance measures : evidence from Australian firms
Pham, Peter Kien; Suchard, Jo-Ann; Zein, Jason - In: Australian journal of management 36 (2011) 3, pp. 371-386
Persistent link: https://www.econbiz.de/10009410611
Cover Image
The generics paradox revisited : empirical evidence from regulated markets
Vandoros, Sotiris; Kanavos, Panos - In: Applied economics 45 (2013) 22/24, pp. 3230-3239
Persistent link: https://www.econbiz.de/10010345456
Cover Image
Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market : evidence from Taiwan
Liu, Ya Ming; Hsieh, Chee-Ruey - In: The B.E. journal of economic analysis & policy 14 (2014) 1, pp. 241-275
Persistent link: https://www.econbiz.de/10010345585
Cover Image
Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market
Bokhari, Farasat A. S.; Yan, Weijie - 2020
pharmaceuticals to examine how incumbents respond to change in the threat of entry. In line with the entry deterrence motive …
Persistent link: https://www.econbiz.de/10012285099
Cover Image
Pharmaceutical prices: the impact of the launch strategy : an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012103333
Cover Image
Pharmaceutical prices : the impact of the launch strategy - an analysis of German data
Böhler, Yvonne-Beatrice; Lamping, Christian; Wichardt, … - 2019 - This Version: September 24, 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012119750
Cover Image
The effects of detailing on prescribing decisions under quality uncertainty
Ching, Andrew; Ishihara, Masakazu - In: Quantitative marketing and economics : QME 8 (2010) 2, pp. 123-165
Persistent link: https://www.econbiz.de/10003977328